Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
Enregistré dans:
Auteurs principaux: | Pathum Sookaromdee, Viroj Wiwanitkit |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wolters Kluwer Medknow Publications
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/16549c0c94e54b9b9db27c4710432494 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Living-donor parathyroid cells allotransplantation in a kidney transplant recipient – Two-year results
par: Vladimir Khryshchanovich, et autres
Publié: (2021) -
Applying a women's health lens to endocrine and metabolic disorders
par: Usha Sriram
Publié: (2021) -
Prevalence of frailty in middle-aged diabetic population of Ahmedabad: A cross-sectional study
par: Priyal P Bhatt, et autres
Publié: (2021) -
Diabetes, COVID-19 and mucormycosis: Unanswered questions!
par: Ashu Rastogi, et autres
Publié: (2021) -
When the DHOL is beating, BHANGRA comes to the rescue!
par: Gagan Priya, et autres
Publié: (2021)